Skip to main content
Not a healthcare professional?
Visit our patient website
Visit our public site
|
Prescribing information
|
Adverse event reporting
Home
About Xenidate XL
About ADHD
Guidelines
Resources
Guidelines for the treatment of ADHD
Long acting Xenidate XL meets NICE treatment guidance for ADHD
NICE guideline 87:
7
Offer methylphenidate (either short or long acting) as the first line pharmacological treatment for children and young people with ADHD
Offer methylphenidate as first-line pharmacological treatment for adults with ADHD
Access the full NICE Guidelines
UK-MET-2025-00007 October 2025